Literature DB >> 3088251

Myoinositol in small preterm infants: relationship between intake and serum concentration.

P Bromberger, M Hallman.   

Abstract

Serum myoinositol (henceforth called inositol) concentration was measured in 12 preterm infants (birth weight 800-1,700 g, gestational age 27-32 weeks) from birth to 10 postnatal weeks. The diet was analyzed for inositol concentration and the daily intake was correlated with serum inositol. There were striking differences in the inositol concentration of infant feedings: preterm colostrum 4.22 +/- 0.51 mM; term colostrum 2.91 +/- 0.21 mM; mature milk 1.81 +/- 0.20 mM; infant formulas 0.09-0.39 mM; parenteral nutrition 0.15 +/- 0.13 mM. The high fetal serum inositol often fell during the first 2 weeks. After 2 weeks, serum inositol correlated significantly with inositol intake (R = 0.601, p less than 0.004). On breast milk serum inositol concentrations (0.56 +/- 0.07 mM) were higher than on formula feedings (0.36 +/- 0.03 mM). Since according to animal studies inositol is important during prenatal growth and differentiation, the present data justify further study on importance of dietary inositol in preterm infants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088251     DOI: 10.1097/00005176-198605000-00021

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

Review 1.  Current perspectives on the drug treatment of neonatal respiratory distress syndrome.

Authors:  D G Sweet; H L Halliday
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

2.  Inositol supplementation in respiratory distress syndrome.

Authors:  M Hallman; M Pohjavuori; K Bry
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Respiratory distress syndrome and inositol supplementation in preterm infants.

Authors:  M Hallman; A L Järvenpää; M Pohjavuori
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

4.  Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.

Authors:  Laura D Brown; Alex Cheung; Jeri E F Harwood; Frederick C Battaglia
Journal:  J Nutr       Date:  2009-06-03       Impact factor: 4.798

5.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk.

Authors:  Dale L Phelps; Robert M Ward; Rick L Williams; Kristi L Watterberg; Abbot R Laptook; Lisa A Wrage; Tracy L Nolen; Timothy R Fennell; Richard A Ehrenkranz; Brenda B Poindexter; C Michael Cotten; Mikko K Hallman; Ivan D Frantz; Roger G Faix; Kristin M Zaterka-Baxter; Abhik Das; M Bethany Ball; T Michael O'Shea; Conra Backstrom Lacy; Michele C Walsh; Seetha Shankaran; Pablo J Sánchez; Edward F Bell; Rosemary D Higgins
Journal:  Pediatr Res       Date:  2013-09-04       Impact factor: 3.756

6.  Inositol in preterm infants at risk for or having respiratory distress syndrome.

Authors:  Alexandra Howlett; Arne Ohlsson; Nishad Plakkal
Journal:  Cochrane Database Syst Rev       Date:  2019-07-08

7.  Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?

Authors:  Antonio Simone Laganà; Vittorio Unfer; Simone Garzon; Mariano Bizzarri
Journal:  Med Hypotheses       Date:  2020-09-09       Impact factor: 1.538

8.  NMR Metabonomic Profile of Preterm Human Milk in the First Month of Lactation: From Extreme to Moderate Prematurity.

Authors:  Chiara Peila; Stefano Sottemano; Flaminia Cesare Marincola; Matteo Stocchero; Nicoletta Grazia Pusceddu; Angelica Dessì; Eugenio Baraldi; Vassilios Fanos; Enrico Bertino
Journal:  Foods       Date:  2022-01-26

9.  Blood myo-inositol concentrations in preterm and term infants.

Authors:  Luc P Brion; Dale L Phelps; Robert M Ward; Tracy L Nolen; N Mikko K Hallman; Abhik Das; Daniel J Zaccaro; M Bethany Ball; Kristi L Watterberg; Ivan D Frantz; C Michael Cotten; Brenda B Poindexter; William Oh; Ralph A Lugo; Krisa P Van Meurs; T Michael O'Shea; Kristin M Zaterka-Baxter; Rosemary D Higgins
Journal:  J Perinatol       Date:  2020-09-15       Impact factor: 2.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.